Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 6/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 6/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17112417 | 0.88 | LPL (0.35) | LPLLIPGTRPV1MGLLCA1 | |
| SCHEMBL1590378 | 0.88 | LPL (0.35) | LPLLIPGTRPV1MGLLCA1 | |
| SCHEMBL411810 | 0.88 | LPL (0.35) | LPLLIPGTRPV1MGLLCA1 | |
| SCHEMBL13480891 | 0.86 | PDK2 (0.32) | LPLLIPGTRPV1MGLLPDK2 | |
| SCHEMBL371497 | 0.84 | LIPG (0.46) | LPLLIPGTRPV1MGLLCA1 | |
| SCHEMBL29383962 | 0.84 | LIPG (0.46) | LPLLIPGTRPV1MGLLCA1 | |
| SCHEMBL29460237 | 0.84 | LIPG (0.46) | LPLLIPGTRPV1MGLLCA1 | |
| SCHEMBL28537539 | 0.84 | LIPG (0.46) | LPLLIPGTRPV1MGLLCA1 | |
| SCHEMBL374243 | 0.84 | LIPG (0.46) | LPLLIPGTRPV1MGLLCA1 | |
| SCHEMBL29453590 | 0.84 | LIPG (0.46) | LPLLIPGTRPV1MGLLCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100270537-A1 | OPTOELECTRONIC DEVICES AND ORGANIC COMPOUNDS USED THEREIN | GENERAL ELECTRIC COMPANY (US) | 2010-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100270537-A1 | OPTOELECTRONIC DEVICES AND ORGANIC COMPOUNDS USED THEREIN | AOC3, C3AR1, AOC2 | LPL 4123/4885LIPG 4430/4885TRPV1 304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.